Metraipolis › archive › dc_598701df076f

Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice — Europe PMC PMID:31682624

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31682624
DOI
10.1371/journal.pone.0224073
License (as archived)
CC0-1.0
Archived
2026-11-10T03:56:30.955Z
SHA-256 of the archived text
99fcab55ca29ee9d8e425224c98c786c81825e12c99d4f4c9ce6f9a928b9136d
Stable URL of this page
https://metraipolis.com/documento/dc_598701df076f

How to cite

Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice — Europe PMC PMID:31682624 — Europe PMC (en), https://europepmc.org/article/MED/31682624 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_598701df076f (Metraipolis archive dc_598701df076f, sha256 99fcab55ca29ee9d8e425224c98c786c81825e12c99d4f4c9ce6f9a928b9136d)
BibTeX
@misc{dc598701df076f,
  title = {Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice — Europe PMC PMID:31682624},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31682624},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_598701df076f; sha256 99fcab55ca29ee9d8e425224c98c786c81825e12c99d4f4c9ce6f9a928b9136d},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31682624. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The development of an effective subunit vaccine is frequently complicated by the difficulty of eliciting protective immune responses, often requiring the co-administration of an adjuvant. Heat-labile toxin (LT), an enterotoxin expressed by enterotoxigenic E. coli (ETEC) with an AB5 structure similar to cholera toxin, is a strong adjuvant. While the mucosa represents the natural route of exposure to LT and related toxins, the clinical utility of LT and similar adjuvants given by mucosal routes has been limited by toxicity, as well as the association between intranasal delivery of LT and Bell's palsy. Single and double amino acid mutants of LT, LT(R192G)/mLT and LT(R192G/L211A)/dmLT respectively, have been proposed as alternatives to reduce the toxicity associated with the holotoxin. In the present study, we compared mLT and dmLT given via a non-mucosal route (i.e. intradermally) to investigate their adjuvanticity when co-administrated with an enterotoxigenic E. coli vaccine candidate, CfaEB. Antigenicity (i.e. ability to elicit response against LT) and reactogenicity at the injection site were also evaluated. BALB/c mice were immunized by the intradermal route with CfaEB plus increasing doses of either mLT or dmLT (0.01 to 2.5 μg). Both adjuvants induced dose-dependent skin reactogenicity, with dmLT being less reactogenic than mLT. Both adjuvants significantly boosted the anti-CfaE IgG and functional hemagglutination inhibiting (HAI) antibody responses, compared to the antigen alone. In addition to inducing anti-LT responses, even at the lowest dose tested (0.01 μg), the adjuvants also prompted in vitro cytokine responses (IFN-γ, IL-4, IL-5, IL-10 and IL-17) that followed different patterns, depending on the protein used for stimulation (CfaE or LTB) and/or the dose used for immunization. The two LT mutants evaluated here, mLT and dmLT, are potent adjuvants for intradermal immunization and should be further investigated for the intradermal delivery of subunit ETEC vaccines.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2019 (prima pubblicazione 2019-11-04).
Identificativi: PMID 31682624 · PMCID PMC6827915 · DOI 10.1371/journal.pone.0224073.
Pagina: https://europepmc.org/article/MED/31682624 — https://doi.org/10.1371/journal.pone.0224073. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-10T03:53:37.496Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.